Parenteral, non-live rotavirus vaccine: recent history and future perspective.

ABSTRACT: Since the widespread introduction of oral and live attenuated rotavirus vaccines around the world in 2009, the impacts of disease burden and the effects of disease reduction in developing countries have been proven. However, in low and middle-income countries, the vaccine efficacy is somewhat lower than in developed countries due to differences in nutritional conditions, microbial environments of individuals, and other factors. In addition, as oral, live vaccines have been found to be associated with rare but serious side effects, the development of a next-generation vaccine with safety, improved effectiveness, and ease of storage is currently underway. New vaccine strain developed by the Centers for Disease Control and Prevention in the United States are undergoing preclinical testing of

SUBMITTER: Song JM 

PROVIDER: S-EPMC8511589 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature